Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-064254

President and CEO sold 16,381 shares at $13.62 ($223,109)

From the SEC's structured data for this filing

Trades in this filing

AHMED NADIM · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Sale : show line 1 in the form −16,381 $13.62 $223,109 404,318 D
Open-market sales · 16,381 sh · avg $13.62 · $223,109
Loading xslF345X05/ownership.xml…